Abstract
Ushbu maqolada zamonaviy farmakologiyaning eng dolzarb yo‘nalishlaridan biri vegetativ nerv tizimiga ta’sir ko‘rsatuvchi dori vositalari, xususan, adrenomimetiklar va adrenoblokatorlarning hujayra va a’zo darajasidagi ta’sir mexanizmlari hamda ularning gipotenziv terapiyadagi o‘rni keng qamrovli tahlil qilingan. Tadqiqot doirasida adrenergik sinapslar, alpha- va beta-retseptorlarning G-oqsil bilan bog‘liq bo‘lgan hujayra ichki ikkinchi messenger tizimlari batafsil yoritilgan.
References
1. Azizova S. S. Farmakologiya [Darslik]. — Toshkent: "Yangi asr avlodi", 2006. 544 b. (Adrenergik tizim va gipotenziv vositalar bo‘limi uchun asosiy manba).
2. Xarkevich D. A. Farmakologiya [O‘zbek tiliga tarjima]. — Moskva: "GEOTAR-Media", 2020. (Xalqaro standartdagi fundamental darslik).
3. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. Arterial gipertoniyani tashxislash va davolash bo‘yicha milliy klinik protokol. — Toshkent, 2023.
4. Brunton L. L., Knollmann B. C. Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 14th Edition. New York: McGraw-Hill Medical, 2023. (Dunyo miqyosidagi farmakologiyaning "Bibliyasi" hisoblanadi).
5. Katzung B. G., Vanderah T. W. Basic & Clinical Pharmacology. 16th Edition. San Francisco: McGraw-Hill, 2024. (Adrenoretseptorlar va kardiologik dori vositalari mexanizmlari qismi uchun).
6. Машковский М. Д. Лекарственные средства. 16-е изд. Москва: "Новая волна", 2020. (Dorilarning batafsil klassifikatsiyasi va xususiyatlari).
7. Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 2018; 39(33): 3021–3104. (Gipotenziv vositalarning zamonaviy kombinatsiyalari mana shu xalqaro protokoldan olingan).
8. Unger T., Borghi C., Charchar F., et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 2020; 75(6): 1334-1357.
9. Flack J. M., Adekola B. Next generation of antihypertensive combination therapies. Current Hypertension Reports, 2021; 23(4): 22-30.

This work is licensed under a Creative Commons Attribution 4.0 International License.